Based in Singapore, Zicom MedTacc is an early stage Venture Capital firm focusing on Seed to Series A start-ups within the Health & Biomedical Sciences industry. With a fund size of around $30 million supported by SPRING Singapore, Zicom MedTacc targets to invest from evolving start-ups to high growth SMEs. With experiences in the local biomedical industry, Zicom MedTacc strategizes to provide guidance and mentorship to assist the start-ups to cultivate business capabilities and build significant business relations within the industry. Zicom MedTacc brings to the table a range of knowledge and services vital to the successful commercialization of a Medtech start-up.